Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


18.03.2019

1 Am J Dermatopathol
1 Anticancer Res
1 Arch Pathol Lab Med
1 Cutis
1 Eur J Dermatol
1 J Am Acad Dermatol
1 J Cell Physiol
2 J Invest Dermatol
2 J Surg Oncol
2 Lancet Child Adolesc Health
6 Melanoma Res
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. AHN C, DeSantis E, McCalmont T
    Oncocytic Metaplasia in Melanocytic Tumors.
    Am J Dermatopathol. 2018 Apr 17. doi: 10.1097/DAD.0000000000001159.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. HANSEN HC, Janssen S, Thieme C, Perlov A, et al
    Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
    Anticancer Res. 2019;39:1343-1346.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  3. GILL P, Howell J, Naugler C, Daoud MSA, et al
    Utility of Multistep Protocols in the Analysis of Sentinel Lymph Nodes in Cutaneous Melanoma: An Assessment of 194 Cases.
    Arch Pathol Lab Med. 2019 Mar 11. doi: 10.5858/arpa.2018-0316.
    PubMed     Text format     Abstract available


    Cutis

  4. LEWELLIS SW, Roy K, Gojenola L, Swetter SM, et al
    Cross-contamination of pathology specimens: a cautionary tale.
    Cutis. 2018;102:E12-E14.
    PubMed     Text format     Abstract available


    Eur J Dermatol

  5. STEMBRIDGE N, Davies A, Chan J, Todd P, et al
    Dermpath and Clinic: A red scaly lesion on the forearm.
    Eur J Dermatol. 2018;28:568-569.
    PubMed     Text format    


    J Am Acad Dermatol

  6. WEI EX, Chen L, Ma F, Keri J, et al
    Recent dermatology visit is associated with thinner Breslow depth nodular melanomas.
    J Am Acad Dermatol. 2019;80:1143-1144.
    PubMed     Text format    


    J Cell Physiol

  7. KO JH, Um JY, Lee SG, Yang WM, et al
    Conditioned media from adipocytes promote proliferation, migration, and invasion in melanoma and colorectal cancer cells.
    J Cell Physiol. 2019 Mar 9. doi: 10.1002/jcp.28456.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  8. NEAL DE, Derwae AL, Etzkorn JR
    Cells to Surgery Quiz: March 2018.
    J Invest Dermatol. 2018;138:e33.
    PubMed     Text format    

  9. GADDIS K, Chu EY
    SnapshotDx Quiz: March 2018.
    J Invest Dermatol. 2018;138:e31.
    PubMed     Text format    


    J Surg Oncol

  10. CIANCIO F, Elia R, Nacchiero E, Perrotta RE, et al
    Current management of regional lymph nodes in patients with melanoma.
    J Surg Oncol. 2019 Mar 12. doi: 10.1002/jso.25443.
    PubMed     Text format    

  11. SINNAMON AJ, Neuwirth MG, Song Y, Schultz SM, et al
    Multispectral photoacoustic imaging for the detection of subclinical melanoma.
    J Surg Oncol. 2019 Mar 15. doi: 10.1002/jso.25447.
    PubMed     Text format     Abstract available


    Lancet Child Adolesc Health

  12. DUFFY D
    MC1R minor variants and the multiple pathways to melanoma.
    Lancet Child Adolesc Health. 2019 Mar 11. pii: S2352-4642(19)30026.
    PubMed     Text format    

  13. PELLEGRINI C, Botta F, Massi D, Martorelli C, et al
    MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.
    Lancet Child Adolesc Health. 2019 Mar 11. pii: S2352-4642(19)30005.
    PubMed     Text format     Abstract available


    Melanoma Res

  14. GRATZ V, Langan EA, Neumann A, Zillikens D, et al
    Acute neurological adverse events during immune checkpoint inhibition therapy in patients with melanoma brain metastases.
    Melanoma Res. 2019 Mar 11. doi: 10.1097/CMR.0000000000000597.
    PubMed     Text format     Abstract available

  15. ORLANDI E, Chiara Z, Albino P, Morena N, et al
    Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk.
    Melanoma Res. 2019 Mar 11. doi: 10.1097/CMR.0000000000000605.
    PubMed     Text format     Abstract available

  16. MANGANA J, Dimitriou F, Braun R, Ludwig S, et al
    Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanoma.
    Melanoma Res. 2019 Mar 11. doi: 10.1097/CMR.0000000000000593.
    PubMed     Text format     Abstract available

  17. MOHN N, Suhs KW, Gingele S, Angela Y, et al
    Acute progressive neuropathy-myositis-myasthenia-like syndrome associated with immune-checkpoint inhibitor therapy in patients with metastatic melanoma.
    Melanoma Res. 2019 Mar 6. doi: 10.1097/CMR.0000000000000598.
    PubMed     Text format     Abstract available

  18. KIANMEHR Z, Khorsandi K, Mohammadi M, Hosseinzadeh R, et al
    Low-level laser irradiation potentiates anticancer activity of p-coumaric acid against human malignant melanoma cells.
    Melanoma Res. 2019 Mar 6. doi: 10.1097/CMR.0000000000000603.
    PubMed     Text format     Abstract available

  19. OUWERKERK W, van den Berg M, van der Niet S, Limpens J, et al
    Biomarkers, measured during therapy, for response of melanoma patients to immune checkpoint inhibitors: a systematic review.
    Melanoma Res. 2019 Mar 7. doi: 10.1097/CMR.0000000000000589.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  20. SANTANA CARRERO RM, Beceren-Braun F, Rivas SC, Hegde SM, et al
    IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses.
    Proc Natl Acad Sci U S A. 2019;116:599-608.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: